Please use this identifier to cite or link to this item: https://doi.org/10.1007/s10126-009-9251-9
Title: Transgenic Expression of Walleye Dermal Sarcoma Virus rv-cyclin Gene in Zebrafish and Its Suppressive Effect on Liver Tumor Development After Carcinogen Treatment
Authors: Zhan, H. 
Spitsbergen, J.M.
Qing, W.
Wu, Y.L. 
Paul, T.A.
Casey, J.W.
Her, G.M.
Gong, Z. 
Keywords: Carcinogen
Liver neoplasia
Transgenic fish
Walleye dermal sarcoma virus rv-cyclin gene
Zebrafish
Issue Date: Nov-2010
Citation: Zhan, H., Spitsbergen, J.M., Qing, W., Wu, Y.L., Paul, T.A., Casey, J.W., Her, G.M., Gong, Z. (2010-11). Transgenic Expression of Walleye Dermal Sarcoma Virus rv-cyclin Gene in Zebrafish and Its Suppressive Effect on Liver Tumor Development After Carcinogen Treatment. Marine Biotechnology 12 (6) : 640-649. ScholarBank@NUS Repository. https://doi.org/10.1007/s10126-009-9251-9
Abstract: A retrovirus homologue gene of cellular cyclin D 1, walleye dermal sarcoma virus rv-cyclin gene (orf A or rv-cyclin), was expressed in the livers of zebrafish under the control of liver fatty acid-binding protein (lfabp) promoter. To prevent possible fatality caused by overexpression of the oncogene, the GAL4/upstream activation sequence (GAL4/UAS) system was used to maintain the transgenic lines. Thus, both GAL4-activator [Tg(lfabp:GAL4)] and UAS-effector [Tg(UAS:rvcyclin)] lines were generated, and the rv-cyclin gene was activated in the liver after crossing these two lines. Since no obvious neoplasia phenotypes were observed in the double-transgenic line, cancer susceptibility of the transgenic fish expressing rv-cyclin was tested by carcinogen treatment. Unexpectedly, transgenic fish expressing rv-cyclin gene (rvcyclin+) were more resistant to the carcinogen than siblings not expressing this gene (rvcyclin-). Lower incidences of multiple and malignant liver tumors were observed in rvcyclin+ than in rvcyclin- fish, and the liver tumors in the rvcyclin+ group appeared later and were less malignant. These results suggest that expression of rv-cyclin protects the fish liver from carcinogen damage and delays onset of malignancy. These findings indicate that transgenic fish models are powerful systems for investigating mechanisms of inhibition and regression of liver tumors. © 2009 Springer Science+Business Media, LLC.
Source Title: Marine Biotechnology
URI: http://scholarbank.nus.edu.sg/handle/10635/114411
ISSN: 14362228
DOI: 10.1007/s10126-009-9251-9
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

12
checked on Nov 14, 2018

WEB OF SCIENCETM
Citations

12
checked on Nov 7, 2018

Page view(s)

88
checked on Nov 16, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.